187 related articles for article (PubMed ID: 20488925)
1. Epstein-Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus.
Ulff-Møller CJ; Nielsen NM; Rostgaard K; Hjalgrim H; Frisch M
Rheumatology (Oxford); 2010 Sep; 49(9):1706-12. PubMed ID: 20488925
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
[TBL] [Abstract][Full Text] [Related]
4. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection.
Dror Y; Blachar Y; Cohen P; Livni N; Rosenmann E; Ashkenazi A
Am J Kidney Dis; 1998 Nov; 32(5):825-8. PubMed ID: 9820454
[TBL] [Abstract][Full Text] [Related]
7. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
Incaprera M; Rindi L; Bazzichi A; Garzelli C
Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
[TBL] [Abstract][Full Text] [Related]
8. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis.
Fafi-Kremer S; Morand P; Brion JP; Pavese P; Baccard M; Germi R; Genoulaz O; Nicod S; Jolivet M; Ruigrok RW; Stahl JP; Seigneurin JM
J Infect Dis; 2005 Mar; 191(6):985-9. PubMed ID: 15717276
[TBL] [Abstract][Full Text] [Related]
9. [Sero-epidemiologic study of Epstein-Barr virus markers in patients without mononucleosis at a department for infectious diseases].
Ternák G; Uj M; Szücs G; Bali I; Almási I; Kócsi J
Orv Hetil; 1995 Dec; 136(50):2727-30. PubMed ID: 8532326
[TBL] [Abstract][Full Text] [Related]
10. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection.
Kanegane H; Wakiguchi H; Kanegane C; Kurashige T; Miyawaki T; Tosato G
Clin Infect Dis; 1999 Apr; 28(4):906-9. PubMed ID: 10825059
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.
Huggins ML; Todd I; Powell RJ
Rheumatol Int; 2005 Apr; 25(3):183-7. PubMed ID: 14666378
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
Stancek D; Robenský J
Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
Kuri A; Jacobs BM; Vickaryous N; Pakpoor J; Middeldorp J; Giovannoni G; Dobson R
BMC Public Health; 2020 Jun; 20(1):912. PubMed ID: 32532296
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-induced systemic lupus erythematosus.
Bhimma R; Adhikari M; Coovadia HM
S Afr Med J; 1995 Sep; 85(9):899-900. PubMed ID: 8545755
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-induced systemic lupus erythematosus?
Keen GA; Yeats J
S Afr Med J; 1996 Jul; 86(7):850. PubMed ID: 8928055
[No Abstract] [Full Text] [Related]
16. Epstein-Barr virus-induced systemic lupus erythematosus.
Matsukawa Y
S Afr Med J; 1996 Jul; 86(7):850-1. PubMed ID: 8764924
[No Abstract] [Full Text] [Related]
17. Hematologic differences in heterophile-positive and heterophile-negative infectious mononucleosis.
Ventura KC; Hudnall SD
Am J Hematol; 2004 Aug; 76(4):315-8. PubMed ID: 15282662
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological analysis of infectious mononucleosis as primary Epstein-Barr virus infection].
Yamamoto T; Yoshida K; Torasawa K; Tada H; Nakamura Y
Rinsho Byori; 1992 Nov; 40(11):1210-6. PubMed ID: 1339163
[TBL] [Abstract][Full Text] [Related]
19. [A quantitative analysis of the cells infected with Epstein-Barr virus in the peripheral blood mononuclear cells derived from the patients with infectious mononucleosis].
Arai T; Yamamoto H; Hirosawa N; Kozima H; Ikezaki A; Okazaki M; Kagimoto S; Joh K; Oh-Ishi T
Rinsho Byori; 1996 Sep; 44(9):853-9. PubMed ID: 8911070
[TBL] [Abstract][Full Text] [Related]
20. [Why are there anti-cardiolipin antibodies in patients with infectious mononucleosis and in patients with systemic lupus erythematosus?].
Dostál C; Palecková A; Novák M; Jahn M; Dostál C
Vnitr Lek; 1990 Nov; 36(11):1050-6. PubMed ID: 2267733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
